Polymorphisms in two particular genes are more prevalent in patients with non-alcoholic steatohepatitis (NASH), patatin-like phospholipase domain-containing 3 (PNPLA3) and transmembrane 6 superfamily member 2 (TM6SF2). The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatohepatitis.